Picture of Repligen logo

RGEN — Repligen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Repligen Q3 Adjusted EPS USD 0.43 Vs. IBES Estimate USD 0.33

Nov 12 (Reuters) - Repligen Q3 adjusted operating income USD 23 million vs.
IBES estimate USD 19.7 million.
* Q3 adjusted net income USD 24 million vs. IBES estimate USD 19.3 million
* Q3 revenue USD 155 million vs. IBES estimate USD 153.2 million
* outlook FY revenue USD 630-639 million

Recent news on Repligen

See all news